Parker A J, O'Leary I K, Wight R G, Clegg R T
Department of Otolaryngology-Head and Neck Surgery, Royal Hallamshire Hospital, Sheffield, England.
J Laryngol Otol. 1992 Feb;106(2):154-6. doi: 10.1017/s0022215100118936.
The Groningen valve was first used in Sheffield in 1986 in a patient who underwent laryngectomy for malignant disease. Since then a further 21 patients have made use of this device, 17 of whom underwent insertion at the time of surgery. All patients were male, two patients have since died and the median length of follow-up to date has been 22.0 (range 2-41) months. Prostheses were replaced mainly under general anaesthesia if they leaked or resulted in difficult phonation. A total of 73 valve insertions have been performed with a median time of 4.0 (range 0.25-27) months between each. Of the 15 men in whom the prosthesis is currently in use, speech was generally good-excellent. The Groningen valve provides a highly acceptable means of obtaining vocalization after laryngectomy in the patients in this series.
1986年，格罗宁根瓣膜首次在谢菲尔德被用于一名因恶性疾病接受喉切除术的患者。从那时起，又有21名患者使用了该装置，其中17名患者在手术时进行了植入。所有患者均为男性，此后有两名患者死亡，迄今为止的中位随访时间为22.0（范围2 - 41）个月。如果假体渗漏或导致发声困难，主要在全身麻醉下更换假体。总共进行了73次瓣膜植入，每次植入之间的中位时间为4.0（范围0.25 - 27）个月。在目前仍在使用假体的15名男性患者中，语音总体良好 - 优秀。在本系列患者中，格罗宁根瓣膜为喉切除术后发声提供了一种高度可接受的方法。
